From Catalyst to Clarity
Photo ID 9988195 © Serialcoder Dreamstime.com Introduction Orphan drugs are therapeutics that treat rare diseases, defined as affecting 200,000 or fewer people in the United States, that normally would not receive investment given the small patient population. Passed in 1983, the Orphan Drug Ac...
Saved in:
| Main Author: | Ezra Chan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia University Libraries
2025-06-01
|
| Series: | Voices in Bioethics |
| Subjects: | |
| Online Access: | https://journals.library.columbia.edu/index.php/bioethics/article/view/13710 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Visual Research of Global Orphan Drug from a Bibliometric Perspective
by: Wen X, et al.
Published: (2025-05-01) -
Current Problems in Provision of Orphan Drugs and Ways to Solve Them
by: Alexei S. Kolbin, et al.
Published: (2016-09-01) -
Quantifying the persisting orphan-drug shortage public health crisis in the United States
by: Szymon Jarosławski, et al.
Published: (2017-01-01) -
Features of intellectual property protection mechanisms on the example of orphan drugs circulation
by: D. S. Yurochkin, et al.
Published: (2022-01-01) -
Using Artificial Intelligence to Advance the Research and Development of Orphan Drugs
by: Carla Irissarry, et al.
Published: (2024-09-01)